LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Rare Variants Associated with Blood Pressure Regulation

By LabMedica International staff writers
Posted on 07 Dec 2020
Print article
Image: Rare genetic differences play vital role in regulating blood pressure (Photo courtesy of British Heart Foundation).
Image: Rare genetic differences play vital role in regulating blood pressure (Photo courtesy of British Heart Foundation).
Genes likely play some role in high blood pressure, heart disease, and other related conditions. However, it is also likely that people with a family history of high blood pressure share common environmental and other potential factors that increase their risk.

High blood pressure, or hypertension, is a common disease in which blood flows through blood vessels at higher than normal pressures. A high force of blood flow can damage and weaken the blood vessels. Over time, hypertension can harm different organs, including the heart, kidneys, brain, and eyes.

A team of scientists at the University of Cambridge (Cambridge, UK) and their colleagues used exome and genotyping arrays for up to 1.3 million individuals of European, African American, South Asian, or Hispanic ancestry enrolled in the large projects such as UK Biobank (UKBB) or in dozens of smaller studies. The team searched for rare variants involved in four main blood pressure-related traits: hypertension, inverse-normal transformed systolic blood pressure, diastolic blood pressure, or pulse pressure. The team relied on exome array-wide association (EAWAS) and rare variant-focused genome-wide association (RV-GWAS) studies and meta-analyses, along with fine-mapping and gene-based analyses, to search for rare variants linked to the blood pressure traits in question.

The investigators found 106 previously undetected loci linked to blood pressure, and dozens of blood pressure-related rare variants, while highlighting enhanced effects for individual rare variants compared to the 1,000 or more common, small effect variants implicated in blood pressure in the past. Just two new loci, in or around the RP11 or VTN genes, had genome-wide significant ties to all of the blood pressure traits considered. Average effects of rare variants were around eight times larger than common variant effects and indicate potential candidate causal genes at new and known loci (for example, GATA5 and PLCB3).

Along with rare variants falling at genes or loci already known to contribute to blood pressure regulation, the team's analysis of common and rare blood pressure-related variants from the new analysis and from studies done before led to active chromatin regions involved in the fetal development of blood vessels, heart, muscle, and other tissues or organs. It also saw genes with potential ties to congenital heart defects, as well as genes with enhanced gene expression during heart development.

Joanna M. M. Howson, PhD, a cardiovascular epidemiologist and a corresponding author of the study, said, “The results from our study indicate rare blood pressure associated variants contribute to blood pressure variability in the general population, and their identification has provided information on new candidate genes and potential causal pathways.” The study was published on November 23, 2020 in the journal Nature Genetics.

Related Links:
University of Cambridge

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more